Tandem Diabetes Care TNDM Accounts Receivable, after Allowance for Credit Loss
Accounts Receivable, after Allowance for Credit Loss at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNet.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's accounts receivable, after allowance for credit loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's accounts receivable, after allowance for credit loss?
- Tandem Diabetes Care (TNDM) reported accounts receivable, after allowance for credit loss of $140.67M in Q1 2026.
- How has Tandem Diabetes Care's accounts receivable, after allowance for credit loss changed year-over-year?
- Tandem Diabetes Care's accounts receivable, after allowance for credit loss increased by 11.1% year-over-year, from $126.56M to $140.67M.
- What is the long-term trend for Tandem Diabetes Care's accounts receivable, after allowance for credit loss?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's accounts receivable, after allowance for credit loss has grown at a 15.0% compound annual growth rate (CAGR), from $82.2M to $165.49M.